Deprecated: Return type of Requests_Cookie_Jar::offsetExists($key) should either be compatible with ArrayAccess::offsetExists(mixed $offset): bool, or the #[\ReturnTypeWillChange] attribute should be used to temporarily suppress the notice in /home/finbold-prod/ on line 63
Skip to content
BIO Bio-Rad Laboratories Inc NYSE
469.87 USD -3.77% -18.41
OPEN 485.83
DAY RANGE 485.83 - 468.25
52 WEEK RANGE 607.54 - 344.63
Interactive Brokers Logotype

Buy BIO stocks now with Interactive Brokers – the most advanced investment platform

Valuations metrics

Market capitalization 12B
Enterprise value 13.5B
Forward pe 25.945333
Peg ratio 25.945333
Price to sales ttm 4.2727876
Price to book mrq 1.4462568
Enterprise to revenue 4.819
Enterprise to ebitda 21.633


Fiscal year ends 2022-12-31
Most recent quarter 2022-12-31
Profit margin -1.29451
Operating margin 0.17376
Return on assets ttm 0.01944
Return on equity ttm -0.31137
Income statement
Revenue ttm 2.8B
Revenue per share ttm 94.083
Quarterly revenue growth -0.003
Gross profit ttm 1.6B
Ebitda 672.7M
Net income to common ttm -3627535104
Diluted eps ttm -116.2
Quarterly earnings growth yoy -0.0033857873354359
Balance sheet
Total cash mrq 1.8B
Total cash per share mrq 60.504
Total debt mrq 1.4B
Total debt to equity mrq 14.437
Current ratio mrq 5.553
Book value per share mrq 324.887
Cash flow
Operating cash flow ttm 194.4M
Levered free cash flow ttm 45.6M

Stock statistics

Shares outstanding 24.5M
Float shares 21.1M
Avg 10 volume 188.8K
Avg 30 volume 191.1K
Shares short 279K
Short ratio 1.55
Short percent of shares outstanding 0.013300001
Percent held by insiders 0.14536001
Percent held by institutions 0.80359

Stock price summary

Fifty two week low 344.63
Fifty two week high 607.54
Fifty two week change -23.434
Beta 0.925289
Day 50 ma 469.433
Day 200 ma 461.23276

Dividends and splits

Last split factor 2-for-1 split
Last split date 2002-03-08

Bio-Rad Laboratories (BIO) company profile

Bio-Rad Laboratories Inc. (NYSE: BIO) is an American company that manufactures and supplies life science research, healthcare, analytical chemistry. The Company’s products and systems are used to separate chemical and biological materials and identify, analyze and purify components. The company operates through the segments of Life Science and Clinical Diagnostics with bases in the United States, Europe, Asia, Canada, and Latin America.